Tower Research Capital (TRC)’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Buy |
12,876
+5,373
| +72% | +$232K | 0.02% | 892 |
|
|
2025
Q1 | $259K | Sell |
7,503
-13,275
| -64% | -$459K | 0.01% | 1222 |
|
|
2024
Q4 | $570K | Buy |
20,778
+18,679
| +890% | +$513K | 0.01% | 970 |
|
|
2024
Q3 | $53.4K | Sell |
2,099
-31,534
| -94% | -$803K | ﹤0.01% | 2686 |
|
|
2024
Q2 | $852K | Buy |
33,633
+32,328
| +2,477% | +$819K | 0.01% | 894 |
|
|
2024
Q1 | $40.4K | Sell |
1,305
-6,912
| -84% | -$214K | ﹤0.01% | 2421 |
|
|
2023
Q4 | $332K | Buy |
8,217
+6,231
| +314% | +$252K | ﹤0.01% | 1700 |
|
|
2023
Q3 | $52.4K | Sell |
1,986
-12,173
| -86% | -$321K | ﹤0.01% | 2514 |
|
|
2023
Q2 | $244K | Buy |
14,159
+9,771
| +223% | +$168K | 0.01% | 1407 |
|
|
2023
Q1 | $72K | Sell |
4,388
-2,096
| -32% | -$34.4K | ﹤0.01% | 2170 |
|
|
2022
Q4 | $50K | Sell |
6,484
-10,311
| -61% | -$79.5K | ﹤0.01% | 2346 |
|
|
2022
Q3 | $167K | Sell |
16,795
-16,018
| -49% | -$159K | ﹤0.01% | 2096 |
|
|
2022
Q2 | $298K | Buy |
32,813
+15,247
| +87% | +$138K | 0.01% | 1486 |
|
|
2022
Q1 | $179K | Buy |
17,566
+1,050
| +6% | +$10.7K | ﹤0.01% | 1812 |
|
|
2021
Q4 | $275K | Buy |
16,516
+4,684
| +40% | +$78K | ﹤0.01% | 1531 |
|
|
2021
Q3 | $554K | Buy |
11,832
+6,485
| +121% | +$304K | 0.01% | 913 |
|
|
2021
Q2 | $326K | Sell |
5,347
-2,232
| -29% | -$136K | 0.01% | 1526 |
|
|
2021
Q1 | $467K | Buy |
7,579
+5,105
| +206% | +$315K | 0.01% | 1294 |
|
|
2020
Q4 | $176K | Sell |
2,474
-897
| -27% | -$63.8K | 0.01% | 1819 |
|
|
2020
Q3 | $127K | Sell |
3,371
-20,405
| -86% | -$769K | ﹤0.01% | 2946 |
|
|
2020
Q2 | $775K | Buy |
+23,776
| New | +$775K | 0.03% | 685 |
|
|
2020
Q1 | – | Sell |
-1,097
| Closed | -$38K | – | 3047 |
|
|
2019
Q4 | $38K | Buy |
1,097
+634
| +137% | +$22K | ﹤0.01% | 1504 |
|
|
2019
Q3 | $10K | Buy |
+463
| New | +$10K | ﹤0.01% | 2913 |
|